196
0
0
Like?
Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan
An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...
Brrr…It’s Cold! Can Blood Nanovesicles Encourage Heat Production and Help Fight Obesity?
Exosomes are cell derived nanovesicles found in all body fluids that mediate intercellular communication...
Developing a modular paper-based detection device for Tuberculosis
The Michigan Synthetic Biology Team is developing a novel diagnostic device that will enable the detection...